Dark Blue Therapeutics - About the company
Dark Blue Therapeutics is an acquired company based in Oxford (United Kingdom), founded in 2020. It operates as a Biotechnology company focused on drugs discovery services. The company has 798 active competitors, including 52 funded and 47 that have exited. Its top competitors include companies like Simulations Plus, Alloy Therapeutics and Manifold Bio.
Company Details
- Website
- darkbluetx.com
- Registered Address
- HAYAKAWA BUILDING, EDMUND HALLEY ROAD,THE OXFORD SCIENCE PARK,OXFORD,UNITED KINGDOM,OX4 4GB
Key Metrics
Founded Year
2020
Location
Oxford, United Kingdom
Stage
Acquired
Ranked
99th among 798 active competitors
Similar Companies
Exit Details
Acquired by Amgen (Jan 06, 2026)
Legal entities associated with Dark Blue Therapeutics
Dark Blue Therapeutics is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
DARK BLUE THERAPEUTICS LTD CIN: 12645831 , United Kingdom, Active | Jun 03, 2020 | - | - |
Dark Blue Therapeutics's acquisition details
Dark Blue Therapeutics got acquired by Amgen on Jan 06, 2026. It was facilitated by Bank of America and Goodwin.
Click here to take a look at Dark Blue Therapeutics's acquisition in detail
Sign up to download Dark Blue Therapeutics' company profile
Dark Blue Therapeutics's funding and investors
Dark Blue Therapeutics has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Dark Blue Therapeutics's Competitors and alternates
Top competitors of Dark Blue Therapeutics include Simulations Plus, Alloy Therapeutics and Manifold Bio. Here is the list of Top 10 competitors of Dark Blue Therapeutics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Simulations Plus 1996, Lancaster (United States), Public | Developer of modeling and simulation software and consulting services provider | - | 65/100 | |
2nd |  Alloy Therapeutics 2017, Lexington (United States), Series D | Provider of drug discovery services | $117M | 62/100 | |
3rd |  Manifold Bio 2018, United States, Series A | Developer of tissue-targeted therapeutics using in vivo screening and AI design | $78.2M | 61/100 | |
4th |  Maiva Pharma 1996, Hosur (India), Late Stage | Manufacturer of sterile injectables | $125M | 61/100 | |
5th | Biotechnology research company developing biological drugs | $160M | 56/100 | ||
6th |  Biocom California 1995, San Diego (United States), Acquired | CRO focused on drug discovery & development for multiple therapeutic areas | - | - | 55/100 |
7th | Service to develop health products aiming to diagnose, prevent, delay the progression or treat hearing loss and tinnitus | $42.3M | 53/100 | ||
8th | Viva Biotech 2006, Shanghai (China), Public | Research services focused on drug discovery and development | - | 51/100 | |
9th |  Superluminal Medicines 2022, Boston (United States), Series A | Generative biological and chemical company focused on drug discovery | $158M | 50/100 | |
10th |  Syenex 2022, Chicago (United States), Series B | Developer of cell-specific delivery systems and programmable cell engineering payloads | $13.7M | 50/100 | |
99th | Dark Blue Therapeutics 2020, Oxford (United Kingdom), Acquired | Biotechnology company focused on drugs discovery services | - | - | 28/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Dark Blue Therapeutics's competitors? Click here to see the top ones
Dark Blue Therapeutics's Investments and acquisitions
Dark Blue Therapeutics has made no investments or acquisitions yet.
News related to Dark Blue Therapeutics
Media has covered Dark Blue Therapeutics for 1 event in last 1 year.
•
Dark Blue Therapeutics acquired by Amgen for up to $840 millionBebeez•Jan 06, 2026•Dark Blue Therapeutics, Amgen, Evotec
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Dark Blue Therapeutics
Explore our recently published companies
- Nsk Ventures - Nashik based, 2024 founded, Unfunded company
- Santech - India based, 2019 founded, Unfunded company
- Gemstone Manufacturing Exporting - Bangkok based, Unfunded company
- Sanj Company - Hong Kong based, 1999 founded, Unfunded company
- Aidreamlab.in - India based, 2026 founded, Unfunded company
- KMD Surgical Solutions - United States based, 2021 founded, Seed company
